Notably, Kaplan-Meier analysis revealed that higher PKM2 or ITGA3 levels were associated with worse OS and worse Progression-Free Survival (PFS) in HCC patients (Figures 7E, F). Here, PKM is linked to hepatocellular carcinoma.